{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:18:00Z","timestamp":1794878280263,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.josat.2026.210138","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:38:40Z","timestamp":1792021120000},"page":"210138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cI couldn't even be in my own skin\u201d: Examining the role of withdrawal pain in the treatment journeys of people who use opioids"],"prefix":"10.1016","volume":"192","author":[{"given":"Tracy R.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajib","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghann","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa N.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210138_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.josat.2026.210138_bb0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11739-024-03604-9","article-title":"Inpatient opioid withdrawal: A qualitative study of the patient perspective","volume":"19","author":"Babbel","year":"2024","journal-title":"Internal and Emergency Medicine"},{"issue":"2","key":"10.1016\/j.josat.2026.210138_bb0015","article-title":"How Geisinger dramatically reduced deaths from opioid use disorder","volume":"1","author":"Barbour","year":"2020","journal-title":"NEJM Catalyst Innovations in Care Delivery"},{"key":"10.1016\/j.josat.2026.210138_bb0020","author":"Beatty"},{"key":"10.1016\/j.josat.2026.210138_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-026-10365-y","article-title":"\u201cYou're hoping for the best, but preparing for the worst\u201d: Discussions of starting buprenorphine in the context of fentanyl use with clinicians and people who use fentanyl","author":"Bhatraju","year":"2026","journal-title":"Journal of General Internal Medicine."},{"key":"10.1016\/j.josat.2026.210138_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107932","article-title":"Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs","volume":"211","author":"Bluthenthal","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2026.210138_bb0035","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/1467-9566.13278","article-title":"Drug fatalities and treatment fatalism: Complicating the ageing cohort theory","volume":"43","author":"Dennis","year":"2021","journal-title":"Sociology of Health & Illness"},{"issue":"2","key":"10.1016\/j.josat.2026.210138_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.55882","article-title":"Prevalence of illicit drug detection in 5 US cities among out-of-treatment people who inject drugs","volume":"9","author":"El-Bassel","year":"2026","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210138_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209616","article-title":"\u201cI still can feel the sickness\u201d: Withdrawal experiences of people on methadone maintenance treatment","volume":"170","author":"Frank","year":"2025","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210138_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12954-023-00893-9","article-title":"\u201cAs safe as possible\u201d: A qualitative study of opioid withdrawal and risk behavior among people who use illegal drugs","volume":"20","author":"Frank","year":"2023","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.210138_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12954-025-01223-x","article-title":"\u201cYou don't have the right resources to let it hurt\u201d: How structural vulnerabilities shape opioid withdrawal experiences among a community sample of people who inject drugs in Los Angeles, California","volume":"22","author":"Ganesh","year":"2025","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.210138_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112953","article-title":"Substances in fentanyl samples in the U.S. illicit drug supply: A decade of trends and regional variations using serial cross-sectional analysis","volume":"277","author":"Hasgul","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210138_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2025.100329","article-title":"Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series","volume":"15","author":"Hayes","year":"2025","journal-title":"Drug and Alcohol Dependence Reports"},{"key":"10.1016\/j.josat.2026.210138_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100133","article-title":"History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder","volume":"6","author":"Heidbreder","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"2","key":"10.1016\/j.josat.2026.210138_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpain.2018.09.001","article-title":"Patients' experience with opioid tapering: A conceptual model with recommendations for clinicians","volume":"20","author":"Henry","year":"2019","journal-title":"The Journal of Pain"},{"issue":"6","key":"10.1016\/j.josat.2026.210138_bb0080","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/add.15260","article-title":"Carfentanil and the rise and fall of overdose deaths in the United States","volume":"116","author":"Jalal","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210138_bb1000","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12954-024-00998-9","article-title":"Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: A retrospective cohort study","volume":"21","author":"Jones","year":"2024","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.josat.2026.210138_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/10826084.2026.2621981","article-title":"Beyond overdose: How people who use drugs navigate competing risks in the polydrug era","author":"Mortensen","year":"2026","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.josat.2026.210138_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/10778004008003008","article-title":"Narrative research: A comparison of two restorying data analysis approaches","volume":"8","author":"Ollerenshaw","year":"2002","journal-title":"Qualitative Inquiry"},{"key":"10.1016\/j.josat.2026.210138_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmmh.2022.100151","article-title":"Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study","volume":"2","author":"Poulsen","year":"2022","journal-title":"SSM - Ment. Health"},{"key":"10.1016\/j.josat.2026.210138_bb1490","article-title":"Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study","volume":"158","author":"Poulsen","year":"2022","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"3","key":"10.1016\/j.josat.2026.210138_bb0100","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1503\/cmaj.74018","article-title":"Buprenorphine-naloxone \u201cmicrodosing\u201d: An alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug market","volume":"192","author":"Randhawa","year":"2020","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.josat.2026.210138_bb0105","series-title":"Narrative methods for the human sciences","author":"Riessman","year":"2008"},{"issue":"4","key":"10.1016\/j.josat.2026.210138_bb0110","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1177\/29767342251330412","article-title":"Outpatient initiation of 7-day injectable buprenorphine: A direct-to-inject case series","volume":"46","author":"Rosenwohl-Mack","year":"2025","journal-title":"Substance Use & Addiction Journal"},{"issue":"12","key":"10.1016\/j.josat.2026.210138_bb0115","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/add.16652","article-title":"Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018\u20132022","volume":"119","author":"Ross","year":"2024","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2026.210138_bb0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/ADM.0000000000001395","article-title":"Examining the severity and progression of illicitly manufactured fentanyl withdrawal: A quasi-experimental comparison","volume":"19","author":"Sharma","year":"2025","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2026.210138_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Substance Abuse"},{"issue":"6","key":"10.1016\/j.josat.2026.210138_bb0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/10826084.2024.2306221","article-title":"Characterizing opioid withdrawal experiences and consequences among a community sample of people who use opioids","volume":"59","author":"Simpson","year":"2024","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2026.210138_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1046648","article-title":"Suboxone: History, controversy, and open questions","volume":"13","author":"Sivils","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.210138_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/17437199.2010.543385","article-title":"Narrative analysis in health psychology research: Personal, dialogical, and social stories of health","volume":"5","author":"Stephens","year":"2011","journal-title":"Health Psychology Review"},{"key":"10.1016\/j.josat.2026.210138_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2026.209893","article-title":"\u201cIt's like scratching at the door\u201d: Experiences of outpatient buprenorphine low dose initiation among people using fentanyl","volume":"184","author":"Suen","year":"2026","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210138_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaging.2021.100990","article-title":"Aging with drug use: Theorizing intersectionally with material gerontology and critical drug studies","volume":"60","author":"Sultan","year":"2022","journal-title":"J. Aging Stud."},{"key":"10.1016\/j.josat.2026.210138_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.06.010","volume":"190","author":"Summers","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210138_bb0155","article-title":"The temporality of the withdrawing body: A qualitative analysis of the role of time in the experience of withdrawing from heroin in prison","author":"Walmsley","year":"2025","journal-title":"Contemporary Drug Problems"},{"issue":"8","key":"10.1016\/j.josat.2026.210138_bb0160","doi-asserted-by":"crossref","first-page":"e2527016","DOI":"10.1001\/jamanetworkopen.2025.27016","article-title":"Injectable-only overlapping buprenorphine starting protocol in a low-threshold setting","volume":"8","author":"Waters","year":"2025","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.josat.2026.210138_bb0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: Buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.210138_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annemergmed.2023.11.020","article-title":"Barriers and facilitators to harm reduction for opioid use disorder: A qualitative study of people with lived experience","volume":"83","author":"Westafer","year":"2023","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.josat.2026.210138_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112895","article-title":"Opioid withdrawal as a barrier to harm reduction: Examining how overdose prevention behaviors are affected by withdrawal","volume":"276","author":"Yi","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210138_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/add.70378","article-title":"Temporal and geographic patterns of nitazene detections in drug samples and biospecimens in the United States, 2019-2024","author":"Zhu","year":"2026","journal-title":"Addiction"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:45:14Z","timestamp":1794876314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":39,"alternative-id":["S2949875926002584"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210138","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cI couldn't even be in my own skin\u201d: Examining the role of withdrawal pain in the treatment journeys of people who use opioids","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210138"}}